Improvement in Psychological Condition of Patients With Persistent Moderate-Severe Allergic Rhinitis by Drug Therapy Combined With Psychological Intervention.

Abstract

OBJECTIVE:

To investigate the effect of drug treatment combined with psychological intervention on mental disorders in patients with persistent moderate-severe allergic rhinitis.

METHODS:

Sixty patients with persistent moderate-severe allergic rhinitis who met the criteria were randomly divided into 2 groups: control group and experimental group. The control group was only given medication, whereas the experimental group was given psychological intervention on the basis of the same medication. Cognitive behavioral therapy was used for psychological intervention. After 12 weeks of treatment, Self-Rating Anxiety Scale (SAS), Self-Rating Depression Scale (SDS), and rhinoconjunctivitis quality of life questionnaire (RQLQ) were used to evaluate the changes in anxiety, depression, and quality of life before and after treatment.

RESULTS:

The SAS and SDS scores of the control group after treatment were lower than those before treatment, and the difference was statistically significant. Similarly, the SAS and SDS scores of the experimental group after treatment were lower than those before treatment with statistically significant difference. In addition, after treatment, the SAS and SDS scores of the experimental group were statistically lower than those of the control group. The results of RQLQ showed that the scores of each dimension in the control group after treatment were lower than those before treatment, and the difference was statistically significant. Similar results were found in the experimental group. After treatment with these 2 different schemes, the RQLQ scores of sleep, nonnasal/eye symptoms, and emotion in the experimental group were statistically lower than those in the control group.

CONCLUSION:

Drug therapy or drug therapy combined with psychological intervention can alleviate anxiety and depression of patients with persistent moderate-severe allergic rhinitis and improve their quality of life. Moreover, based on the effect of improving mental disorder and quality of life of patients, drug therapy combined with psychological intervention is better than drug treatment alone.

• Authors: Li-Xin Wang, Zhi-Chao Yang, Zhao-Peng Kang, Ling-Ling Di, Yan Tan, Xian-Bing Peng, Jie Liu
• Journal: Ear, nose, & throat journal (Ear Nose Throat J) Vol. 100 Issue 5_suppl Pg. 684S-690S (Sep 2021) ISSN: 1942-7522 [Electronic] United States
• PMID: 32050792 (Publication Type: Journal Article, Randomized Controlled Trial)

Chemical References

• Anti-Allergic Agents
• Mometasone Furoate
• Loratadine

Topics

• Adolescent
• Adult
• Anti-Allergic Agents (therapeutic use)
• Anxiety
• Cognitive Behavioral Therapy
• Combined Modality Therapy
• Depression
• Drug Therapy, Combination
• Female
• Humans
• Loratadine (therapeutic use)
• Male
• Middle Aged
• Mometasone Furoate (administration & dosage)
• Psychosocial Intervention
• Quality of Life
• Rhinitis, Allergic (drug therapy, psychology, therapy)
• Self Report